--Cisco Systems to Eliminate Thousands of Jobs in Second Workforce Reduction This Year, Reuters Says-March 2024-www.financetom.com

--Cisco Systems to Eliminate Thousands of Jobs in Second Workforce Reduction This Year, Reuters Says

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Cisco Systems to Eliminate Thousands of Jobs in Second Workforce Reduction This Year, Reuters Says

Aug 9, 2024 8:44 AM

11:16 AM EDT, 08/09/2024 (MT Newswires) --

Price: 45.56, Change: -0.27, Percent Change: -0.59

Previous page： Peltz's Trian, General Catalyst raise offer for Janus Henderson Next page： Core & Main Fiscal Q4 Adjusted Earnings Increase, Net Sales Decrease; Fiscal 2026 Sales Guidance Initiated

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Peltz's Trian, General Catalyst raise offer for Janus Henderson

Mar 24, 2026

March 24 (Reuters) - Janus Henderson ( JHG ) said on Tuesday that Trian and General Catalyst have raised their bid to acquire the asset manager to $52 per share. The new offer, which represents a 25% premium to Janus' unaffected stock price and is $3 per share higher than the previous bid, comes amid a high-stakes battle with Victory...

Core & Main Fiscal Q4 Adjusted Earnings Increase, Net Sales Decrease; Fiscal 2026 Sales Guidance Initiated

Mar 24, 2026

08:11 AM EDT, 03/24/2026 (MT Newswires) -- Core & Main ( CNM ) reported fiscal Q4 adjusted earnings Tuesday of $0.52 per diluted share, up from $0.51 a year earlier. Analysts polled by FactSet expected $0.48. Net sales for the fiscal quarter ended Feb. 1 were $1.58 billion, down from $1.70 billion a year earlier. Analysts surveyed by FactSet expected...

Karyopharm's drug reduces spleen size in rare blood cancer study

Mar 24, 2026

March 24 (Reuters) - Karyopharm Therapeutics ( KPTI ) said on Tuesday its therapy for patients with a rare blood cancer showed a reduction in spleen size in a late-stage trial, meeting one of the two main goals of the study. Shares of the company were up nearly 14% in premarket trade. In the 353-patient trial, half of those given...

BRIEF-1Gt Portfolio Investment Huel To Be Acquired By Danone

Mar 24, 2026

Morgan Stanley ( MS ): * 1GT PORTFOLIO INVESTMENT HUEL TO BE ACQUIRED BY DANONE Source text: Further company coverage: ...